New Mexico legislation · 2026 Regular Session
New Mexico SB130: NO COST-SHARING OF CERTAIN DRUGS
Status: In committee, February 17, 2026
What the bill says
An act relating to health care; amending sections of the new mexico insurance code to prohibit cost sharing for generic medications used for the treatment of cholesterol disorder, second-line step therapy medications and coronary artery calcium screening under certain circumstances; broadening eligibility for coronary artery calcium screening and cholesterol lipid panels; excepting certain plans; creating new duties for the board of pharmacy.
From the committee substitute text, February 17, 2026:
AN ACT RELATING TO HEALTH CARE; AMENDING SECTIONS OF THE NEW MEXICO INSURANCE CODE TO PROHIBIT COST SHARING FOR GENERIC MEDICATIONS USED FOR THE TREATMENT OF CHOLESTEROL DISORDER, SECOND-LINE STEP THERAPY MEDICATIONS AND CORONARY ARTERY CALCIUM SCREENING UNDER CERTAIN CIRCUMSTANCES; BROADENING ELIGIBILITY FOR CORONARY ARTERY CALCIUM SCREENING AND CHOLESTEROL LIPID PANELS; EXCEPTING CERTAIN PLANS; CREATING NEW DUTIES FOR THE BOARD OF PHARMACY. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO: SECTION 1. A new section of Chapter 59A, Article 22 NMSA 1978 is enacted to read: "[NEW MATERIAL] CORONARY ARTERY CALCIUM SCREENING AND CHOLESTEROL LIPID PANELS COVERAGE.-- A. An individual or group health insurance policy, .233915.1 wen = lairetam derocsrednu eteled = ]lairetam detekcarb[ SHPAC/SB health care plan or certificate of health insurance that is delivered, issued for delivery or renewed in this state shall provide coverage for an eligible insured to receive a coronary artery calcium screening and low-density lipoprotein panels. B. Coverage provided pursuant to this section shall: (1) be limited to the provision of a coronary artery calcium screening to an eligible insured at the discretion of a health care provider to be used as a clinical management tool; (2) be provided every five years if an eligible insured has previously received a coronary artery calcium score of zero; (3) not be required …
Sponsors
- Martin Hickey (D, SD-020) · primary sponsor
Latest actions
- : SHPAC: Reported by committee with Do Not Pass but with a Do Pass recommendation on Committee Substitution
- : Sent to committee - Referrals: SHPAC
- : STBTC ref w/drn
- : SCC: Reported by committee to fall within the purview of a 30 day session
- : Sent to SCC - Referrals: SCC/SHPAC/STBTC
- : Action Postponed Indefinitely
Subjects: HEALTH & HEALTH FACILITIES
Common questions
- What is SB130?
- SB130 is a bill in the New Mexico Legislature (2026 Regular Session): NO COST-SHARING OF CERTAIN DRUGS.
- What does SB130 do?
- In its own words: An act relating to health care; amending sections of the new mexico insurance code to prohibit cost sharing for generic medications used for the treatment of cholesterol disorder, second-line step therapy medications and coronary artery calcium screening under certain circumstances; broadening eligibility for coronary artery calcium screening and cholesterol lipid panels; excepting certain plans; creating new duties for the board of pharmacy.
- What is the status of SB130?
- In committee as of February 17, 2026. Latest action: SHPAC: Reported by committee with Do Not Pass but with a Do Pass recommendation on Committee Substitution (February 17, 2026).
- Who sponsored SB130?
- Martin Hickey (D, SD-020).
- Where is the official record for SB130?
- On the New Mexico Legislature website: https://www.nmlegis.gov/Legislation/Legislation?chamber=S&legType=B&legNo=130&year=26
Source: official New Mexico record. Tracked by Delilah, AI for legislation across all 50 states and Congress.